Skip to content
IV Injection Allopathic

Thymoglobulin 25 mg/10 ml iv injection

Generic: Anti-Thymocyte Globulin

Company: Synovia Pharma PLC.. Prices are as listed on BestinMeds; your pharmacy price may differ.

Strength25 mg/10 ml
PackNot listed yet

Reviewed by: not listed yet. Source: not listed yet.

Last updated February 25, 2025.

Compare

Same generic, same strength

Sorted by price per iv injection. Ask your pharmacist before you switch brands.

Anti-Thymocyte Globulin 25 mg/10 ml iv injections

Prices as listed on BestinMeds.

No price is listed for this strength yet.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250
Medicine guide

About this medicine

What this medicine is for, how to take it, and what to watch for.

Read the full Anti-Thymocyte Globulin guide

Indications

Renal transplant Anti-Thymocyte Globulin is an immunoglobulin G indicated for the prophylaxis and treatment of acute rejection in patients receiving a kidney transplant. Use in conjunction with concomitant immunosuppression.

Dosage and administration

The first dose should be infused over at least 6 hours; doses on subsequent days should be infused over at least 4 hours. Premedication with corticosteroids, acetaminophen, and/or an antihistamine prior to each infusion is recommended. The Anti-Thymocyte Globulin dose should be reduced by one half if the white blood cell (WBC) count is between 2,000 and 3,000 cells/mm3 or if the platelet count is between 50,000 and 75,000 cells/mm3. Stopping Anti-Thymocyte Globulin treatment should be considered if the WBC count falls below 2,000 cells/mm3 or if the platelet count falls below 50,000 cells/mm3 Prophylaxis of acute rejection: 1.5 mg/kg of body weight administered daily for 4 to 7 days Treatment of acute rejection: 1.5 mg/kg of body weight administered daily for 7 to 14 days

Side effects

The most common adverse reactions and laboratory abnormalities (incidence>5% higher than comparator) are urinary tract infection, abdominal pain, hypertension, nausea, shortness of breath, fever, headache, anxiety, chills, increased potassium levels in the blood, low counts of platelets and white blood cells

Precautions and warnings

Anti-Thymocyte Globulin should only be used by physicians experienced in immunosuppressant therapy in transplantation. Immune-mediated reactions: Anti-Thymocyte Globulin infusion could result in an anaphylactic reaction. Infusion-associated reactions: Close compliance with the recommended infusion time may reduce the incidence and severity of infusion-associated reactions. Hematologic effects: low counts of platelets and white blood cells have been identified and are reversible following dose adjustments. Monitor total white blood cell and platelet counts. Infection: Infections and reactivation of infections have been reported. Monitor patients and administer anti-infective prophylaxis. Malignancy: Incidence of malignancies may increase. Immunization with attenuated live vaccines is not recommended for patients who have recently received THYMOGLOBULIN. THYMOGLOBULIN may interfere with rabbit antibody–based immunoassays and with cross-match or panel-reactive antibody cytotoxicity assays.

Pregnancy and lactation

Animal reproduction studies have not been conducted with Anti-Thymocyte Globulin. It is also not known whether Anti-Thymocyte Globulin can cause fetal harm. Anti-Thymocyte Globulin should be given to a pregnant woman only if the benefit outweighs the risk. Anti-Thymocyte Globulin has not been studied in nursing women. It is not known whether this drug is excreted in human milk. Because other immunoglobulins are excreted in human milk, breastfeeding should be discontinued during Anti-Thymocyte Globulin therapy.

Clinical details

BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250